Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL
about
Biosynthesis of dermatan sulfate: chondroitin-glucuronate C5-epimerase is identical to SART2Iduronic acid in chondroitin/dermatan sulfate: biosynthesis and biological functionExpression of tumor-rejection antigens in gynecologic cancersMicroarray analysis of gene-expression profiles in diffuse large B-cell lymphoma: identification of genes related to disease progressionSerine proteinase inhibitor 9 can be recognized by cytotoxic T lymphocytes of epithelial cancer patientsExpression of tumor rejection antigens in colorectal carcinomasCleavage and polyadenylation specificity factor (CPSF)-derived peptides can induce HLA-A2-restricted and tumor-specific CTLs in the majority of gastrointestinal cancer patientsTCR reconstitution in Jurkat reporter cells facilitates the identification of novel tumor antigens by cDNA expression cloning.Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma.Gene expression in uninvolved oral mucosa of OSCC patients facilitates identification of markers predictive of OSCC outcomes.EGFR T790M mutation as a possible target for immunotherapy; identification of HLA-A*0201-restricted T cell epitopes derived from the EGFR T790M mutationHeat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells.Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cellsA listing of human tumor antigens recognized by T cells: March 2004 update.Dermatan sulfate is involved in the tumorigenic properties of esophagus squamous cell carcinoma.Melanoma Cell Adhesion and Migration Is Modulated by the Uronyl 2-O Sulfotransferase.Identification of B cell epitopes reactive to human papillomavirus type-16L1- derived peptides.Detection of peptide-specific CTL-precursors in peripheral blood lymphocytes of cancer patients.UDP-Gal: betaGlcNAc beta1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumour antigen recognised by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumourA phase I trial of cytotoxic T-lymphocyte precursor-oriented peptide vaccines for colorectal carcinoma patientsHLA-A2-restricted cytotoxic T lymphocyte epitopes from human heparanase as novel targets for broad-spectrum tumor immunotherapy.Mobilizing the low-avidity T cell repertoire to kill tumors.Update on vaccine development for renal cell cancer.Biological functions of iduronic acid in chondroitin/dermatan sulfate.Musculocontractural Ehlers-Danlos syndrome and neurocristopathies: dermatan sulfate is required for Xenopus neural crest cells to migrate and adhere to fibronectinDecorin and its galactosaminoglycan chain: extracellular regulator of cellular function?Dermatan sulfate epimerase 1-deficient mice have reduced content and changed distribution of iduronic acids in dermatan sulfate and an altered collagen structure in skin.Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma.Expression of chondroitin-glucuronate C5-epimerase and cellular immune responses in patients with hepatocellular carcinoma.The amino acid tryptophan prevents the biosynthesis of dermatan sulfate.Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer.Two dermatan sulfate epimerases form iduronic acid domains in dermatan sulfate.Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+ glioma patients.The subclonal structure and genomic evolution of oral squamous cell carcinoma revealed by ultra-deep sequencingIdentification of cyclophilin B-derived peptides capable of inducing histocompatibility leukocyte antigen-A2-restricted and tumor-specific cytotoxic T lymphocytes.Identification of Lck-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with distant metastases.Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma.P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma.IgG reactive to CTL-directed epitopes of self-antigens is either lacking or unbalanced in atopic dermatitis patients.Immunological monitoring during combination of patient-oriented peptide vaccination and estramustine phosphate in patients with metastatic hormone refractory prostate cancer.
P2860
Q24306073-580BA2D6-2E84-407E-AC68-72E5BF5D3352Q26851742-83400991-62CF-4D67-80B3-182D2BF0C3AAQ28138549-358646A7-7A45-41DC-87C6-3B27E62D454AQ28201324-9AAAA170-0A5C-4CCD-BBA6-CE4A24F11810Q28202640-A1E7A4B8-908D-4F45-96E5-C7E6099317AEQ28211063-B3662C43-B2F7-4081-AD65-3D58E4FDD317Q28216625-D21B1B46-6E2E-45DD-8D19-16219B5BB74BQ30831500-BF863A34-CBBA-46A0-BA11-648CA1EB7AE2Q31114927-B07B5287-A47C-4EB5-9EAA-5877314C6195Q34431421-85256A25-700D-4BF0-A9CD-D414995C7343Q35040888-BEFBCA0E-6ED2-4135-B38B-89A7F6994C48Q35051440-D6CCF8C7-6CFB-41DA-9295-4D3820242380Q35640277-2982EA16-4D40-49EA-8907-151735138C05Q35862179-ED3A4EF6-810A-429A-A5C1-0CCA2720B240Q35894756-CCD39012-3C32-4D3A-8320-CDB12759EA04Q36255478-38FF81C1-9E26-4D15-A8AB-CC5D29EAA04CQ36295220-A4A12656-FCBD-4578-A2E6-D261CE990D87Q36624130-8702A8DD-F515-4B7D-9522-1FF9FE9273EEQ36624402-73F01DA9-2308-4718-9E3E-596D91273EABQ36694874-8804DF84-19CE-47FC-A5C2-FD034225A106Q36840281-8DD44CC0-9545-4F7B-A69D-198B2767AA6BQ36891310-E1291458-7A79-4D2B-8303-862CBBA8318CQ36989720-0A7AF27F-2C51-4636-9E21-53C28314102BQ37029047-7DDD710B-C528-4271-B237-99BEB55F60CFQ37036162-35EA3066-26C7-4A63-8574-05B0B2041A78Q37272650-8F5DC665-702F-4183-A430-E71428A3E6A0Q37374758-42D04659-B95A-41AC-BD4D-7E68A56C9730Q37600523-97E4A81C-6E12-49EE-B417-859C0C627F3DQ39308470-BD6C048E-12ED-43CA-9B3A-848F19CDFECFQ39500396-74C90B17-FB8A-41F8-92F8-BB214F72198DQ39764766-F84A1355-50CF-4EDB-93F5-7E8A72609508Q39888277-D98CACFD-0C11-47FA-B114-509D654D1397Q39946155-8CB36046-F083-4E10-A945-EE89CBD147D3Q42183763-B001991C-A7D1-439D-8877-A3E1A4BA691DQ43688390-6A0D355E-76B6-46F2-87B5-1043DFB21A5DQ43773473-CCE932C0-1835-4F0E-B33D-FB550CBB64A3Q44234947-A89569F7-E06D-4983-B893-ED46574DA074Q44269708-870316C2-0BC0-47E6-AFE6-30E27B53E487Q44445402-9911F577-70CE-4B47-9E81-3D3ECAB46A0CQ44885394-1A488F18-8859-442B-B606-2D406DD0E184
P2860
Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Identification of a gene codin ...... antigen recognized by the CTL
@ast
Identification of a gene codin ...... antigen recognized by the CTL
@en
Identification of a gene codin ...... antigen recognized by the CTL
@en-gb
Identification of a gene codin ...... antigen recognized by the CTL
@nl
type
label
Identification of a gene codin ...... antigen recognized by the CTL
@ast
Identification of a gene codin ...... antigen recognized by the CTL
@en
Identification of a gene codin ...... antigen recognized by the CTL
@en-gb
Identification of a gene codin ...... antigen recognized by the CTL
@nl
prefLabel
Identification of a gene codin ...... antigen recognized by the CTL
@ast
Identification of a gene codin ...... antigen recognized by the CTL
@en
Identification of a gene codin ...... antigen recognized by the CTL
@en-gb
Identification of a gene codin ...... antigen recognized by the CTL
@nl
P2093
P3181
P1476
Identification of a gene codin ...... antigen recognized by the CTL
@en
P2093
K Matsunaga
S Shichijo
P304
P3181
P356
10.4049/JIMMUNOL.164.5.2565
P407
P577
2000-03-01T00:00:00Z